{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:34:04Z","timestamp":1794105244175,"version":"4.8.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.475522\/2020-00"],"award-info":[{"award-number":["88887.475522\/2020-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00415-025-13120-1","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T13:04:00Z","timestamp":1748178240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cognitive manifestations and brain integrity in hereditary transthyretin amyloidosis: a systematic review"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5331-946X","authenticated-orcid":false,"given":"Iara","family":"Senem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2025-3633","authenticated-orcid":false,"given":"Rodrigo Melo","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1420-2423","authenticated-orcid":false,"given":"Maria Paula","family":"Foss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3731-3612","authenticated-orcid":false,"given":"Jan","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1536-1277","authenticated-orcid":false,"given":"Jonas","family":"Wixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4589-2749","authenticated-orcid":false,"suffix":"Jr","given":"Wilson","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"13120_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","volume":"15","author":"D Adams","year":"2019","unstructured":"Adams D, Koike H, Slama M, Coelho T (2019) Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol 15:387\u2013404","journal-title":"Nat Rev Neurol"},{"key":"13120_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012965","author":"L Sousa","year":"2021","unstructured":"Sousa L, Coelho T, Taipa R (2021) CNS involvement in hereditary transthyretin amyloidosis. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000012965","journal-title":"Neurology"},{"key":"13120_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00401-022-02501-9","volume":"145","author":"R Taipa","year":"2022","unstructured":"Taipa R, Sousa L, Pinto M, Reis I, Rodrigues A, Oliveira P, Melo-Pires M, Coelho T (2022) Neuropathology of central nervous system involvement in TTR amyloidosis. Acta Neuropathol 145:113\u2013126","journal-title":"Acta Neuropathol"},{"key":"13120_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s40120-020-00217-0","volume":"9","author":"MA Liz","year":"2020","unstructured":"Liz MA, Coelho T, Bellotti V, Fernandez-Arias MI, Mallaina P, Obici L (2020) A narrative review of the role of transthyretin in health and disease. Neurol Therapy 9:395\u2013402","journal-title":"Neurol Therapy"},{"key":"13120_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1600-0447.1951.tb09673.x","volume":"26","author":"C Andrade","year":"1952","unstructured":"Andrade C (1952) A peculiar form of peripheral neuropathy: familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Acta Psychiatr Neurol Scand 26:251\u2013257","journal-title":"Acta Psychiatr Neurol Scand"},{"key":"13120_CR6","first-page":"809","volume":"27","author":"JdS Horta","year":"1964","unstructured":"Horta JdS, Filipe I, Duarte S (1964) Portuguese polyneuritic familial type of amyloidosis. Pathol Microbiol 27:809\u2013825","journal-title":"Pathol Microbiol"},{"key":"13120_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13507","author":"H Durmu\u015f","year":"2021","unstructured":"Durmu\u015f H, \u00c7akar A, Demirci H, Alaylioglu M, Gezen-Ak D, Dursun E, G\u00fcl\u015fen Parman Y (2021) An exploratory study of cognitive involvement in hereditary transthyretin amyloidosis. Acta Neurol Scand. https:\/\/doi.org\/10.1111\/ane.13507","journal-title":"Acta Neurol Scand"},{"key":"13120_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2017.1335639","author":"V Freitas Castro","year":"2017","unstructured":"Freitas Castro V, Nascimento Alves P, Franco A, Martins I, Concei\u00e7\u00e3o I (2017) Cognitive impairment in liver transplanted patients with transthyretin-related hereditary amyloid polyneuropathy. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. https:\/\/doi.org\/10.1080\/13506129.2017.1335639","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"13120_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00415-017-8668-8","volume":"265","author":"A Martins da Silva","year":"2018","unstructured":"Martins da Silva A, Cavaco S, Fernandes J, Sam\u00f5es R, Alves C, Cardoso M, Kelly JW, Monteiro C, Coelho T (2018) Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis. J Neurol 265:299\u2013307","journal-title":"J Neurol"},{"key":"13120_CR10","unstructured":"Porto CM, Sougey E, Silva T, Diniz P, Sousa R, Le\u00e3o R (2018) Brain changes in the neuroimaging of adult patients with vitamin D deficiency: a protocol for a systematic review of qualitative evidence. PROSPERO CRD42018100074. Available from https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42018100074"},{"key":"13120_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.01.017","author":"A Mazzeo","year":"2006","unstructured":"Mazzeo A, Toscano A, Stromillo M, Battaglini M, Messina C, Federico A, Vita G, De Stefano N (2006) Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2006.01.017","journal-title":"J Neurol Sci"},{"key":"13120_CR12","volume-title":"JBI manual for evidence synthesis","author":"S Moola","year":"2020","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetc R, Currie M, Lisy K, Qureshi R, Mattis P, Mu P-F (2020) Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds) JBI manual for evidence synthesis. JBI"},{"key":"13120_CR13","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. https:\/\/doi.org\/10.11124\/JBISRIR-D-19-00099","journal-title":"JBI Evid Synth"},{"key":"13120_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2020.1835263","author":"M Benson","year":"2020","unstructured":"Benson M, Buxbaum J, Eisenberg D, Merlini G, Saraiva M, Sekijima Y, Sipe J, Westermark P (2020) Amyloid nomenclature 2020: update and recommendations by the international society of amyloidosis (ISA) nomenclature committee. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. https:\/\/doi.org\/10.1080\/13506129.2020.1835263","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"13120_CR15","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000287089.28847.b5","author":"T Yamashita","year":"2008","unstructured":"Yamashita T, Ando Y, Ueda M, Nakamura M, Okamoto S, Zeledon M, Hirahara T, Hirai T, Ueda A, Misumi Y, Obayashi K, Inomata H, Uchino M (2008) Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000287089.28847.b5","journal-title":"Neurology"},{"key":"13120_CR16","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2012.682187","author":"F Salvi","year":"2012","unstructured":"Salvi F, Pastorelli F, Plasmati R, Bartolomei I, Dall\u2019Osso D, Rapezzi C (2012) Genotypic and phenotypic correlation in an Italian population of hereditary amyloidosis TTR-related (HA-TTR): clinical and neurophysiological aids to diagnosis and some reflections on misdiagnosis. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. https:\/\/doi.org\/10.3109\/13506129.2012.682187","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"13120_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/13506129.2022.2131384","volume":"30","author":"S Cavaco","year":"2023","unstructured":"Cavaco S, Martins da Silva A, Fernandes J, Sousa AP, Alves C, Cardoso M, Teixeira-Pinto A, Coelho T (2023) Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant. Amyloid 30:119\u2013126","journal-title":"Amyloid"},{"issue":"2","key":"13120_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jnnp.2006.093500","volume":"78","author":"C Douglass","year":"2007","unstructured":"Douglass C, Suvarna K, Reilly M, Hawkins P, Hadjivassiliou M (2007) A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia. J Neurol Neurosurg Psychiatry 78(2):193\u2013195. https:\/\/doi.org\/10.1136\/jnnp.2006.093500","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13120_CR19","doi-asserted-by":"publisher","DOI":"10.3233\/JND-200542","author":"F Kleefeld","year":"2020","unstructured":"Kleefeld F, Knebel F, Eurich D, Schatka I, Bl\u00fcthner E, Sch\u00f6nfeld S, Amthauer H, Hahn K (2020) Familial oculo-leptomeningeal transthyretin amyloidosis caused by Leu55Arg mutation. J Neuromuscul Dis. https:\/\/doi.org\/10.3233\/JND-200542","journal-title":"J Neuromuscul Dis"},{"key":"13120_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.05.014","author":"K Nakagawa","year":"2008","unstructured":"Nakagawa K, Sheikh S, Snuderl M, Frosch M, Greenberg S (2008) A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2008.05.014","journal-title":"J Neurol Sci"},{"key":"13120_CR21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.6.1562","author":"F Garzuly","year":"1996","unstructured":"Garzuly F, Vidal R, Wisniewski T, Brittig F, Budka H (1996) Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology. https:\/\/doi.org\/10.1212\/WNL.47.6.1562","journal-title":"Neurology"},{"key":"13120_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-9125-z","author":"K Fan","year":"2019","unstructured":"Fan K, Zhu H, Xu H, Mao P, Yuan L, Deng H (2019) The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis. J Neurol. https:\/\/doi.org\/10.1007\/s00415-018-9125-z","journal-title":"J Neurol"},{"key":"13120_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2018.07.030","author":"S Beckius","year":"2018","unstructured":"Beckius S, Shah K (2018) Intracranial and systemic manifestations of familial leptomeningeal amyloidosis, as seen on CT and MRI. Radiol Case Rep. https:\/\/doi.org\/10.1016\/j.radcr.2018.07.030","journal-title":"Radiol Case Rep"},{"key":"13120_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.2.183","author":"M Brett","year":"1999","unstructured":"Brett M, Persey M, Reilly M, Revesz T, Booth D, Booth S, Hawkins P, Pepys M, Morgan-Hughes J (1999) Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain J Neurol. https:\/\/doi.org\/10.1093\/brain\/122.2.183","journal-title":"Brain J Neurol"},{"issue":"Suppl","key":"13120_CR25","first-page":"1","volume":"18","author":"J Liepnieks","year":"2011","unstructured":"Liepnieks J, Dickson D, Benson M (2011) A new transthyretin mutation associated with leptomeningeal amyloidosis. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 18(Suppl):1","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"13120_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.015","author":"F Salvi","year":"2015","unstructured":"Salvi F, Pastorelli F, Plasmati R, Morelli C, Rapezzi C, Bianchi A, Mascalchi M (2015) Brain microbleeds 12 years after orthotopic liver transplantation in Val30Met amyloidosis. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.02.015","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"key":"13120_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jns.2009.04.015","volume":"284","author":"A Bersano","year":"2009","unstructured":"Bersano A, Del Bo R, Ballabio E, Cinnante C, Lanfranconi S, Comi G, Baron P, Bresolin N, Candelise L (2009) Transthyretin Asn90 variant: amyloidogenic or non-amyloidogenic role. J Neurol Sci 284:113\u2013115.\u00a0https:\/\/doi.org\/10.1016\/j.jns.2009.04.015","journal-title":"J Neurol Sci"},{"key":"13120_CR28","doi-asserted-by":"publisher","DOI":"10.1159\/000084299","author":"A Lossos","year":"2005","unstructured":"Lossos A, Soffer D, Steiner-Birmanns B, Hassin-Baer S, Sadeh M, Sagi M, Linetski E, Abramsky O, Argov Z, Rosenmann H (2005) Extended phenotype in the transthyretin Tyr77 familial amyloid polyneuropathy. Eur Neurol. https:\/\/doi.org\/10.1159\/000084299","journal-title":"Eur Neurol"},{"key":"13120_CR29","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.7.1498","author":"M Mascalchi","year":"1999","unstructured":"Mascalchi M, Salvi F, Pirini M, D\u2019Errico A, Ferlini A, Lolli F, Plasmati R, Tessa C, Villari N, Tassinari C (1999) Transthyretin amyloidosis and superficial siderosis of the CNS. Neurology. https:\/\/doi.org\/10.1212\/WNL.53.7.1498","journal-title":"Neurology"},{"key":"13120_CR30","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.40.259","author":"M Owa","year":"2001","unstructured":"Owa M, Takei Y, Hashikura Y, Kawasaki S, Koyama M, Ikeda S (2001) Recurrent cerebral embolism in a familial amyloid polyneuropathy patient who received partial liver transplantation from a living donor. Intern Med. https:\/\/doi.org\/10.2169\/internalmedicine.40.259","journal-title":"Intern Med"},{"key":"13120_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000065901.18353.AB","author":"G Blevins","year":"2003","unstructured":"Blevins G, Macaulay R, Harder S, Fladeland D, Yamashita T, Yazaki M, Hamidi AK, Benson M, Donat J (2003) Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology. https:\/\/doi.org\/10.1212\/01.WNL.0000065901.18353.AB","journal-title":"Neurology"},{"key":"13120_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-04176-9","author":"E Dardiotis","year":"2020","unstructured":"Dardiotis E, Andreou S, Aloizou A, Panayiotou E, Siokas V, Ioannou M, Vounou E, Christodoulou K, Tanteles G, Michaelides D, Kyriakides T (2020) The frequency of central nervous system complications in the cypriot cohort of ATTRV30M neuropathy transplanted patients. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. https:\/\/doi.org\/10.1007\/s10072-019-04176-9","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"13120_CR33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/01616412.2023.2208470","volume":"45","author":"A Di Paolantonio","year":"2023","unstructured":"Di Paolantonio A, Romano A, Guglielmino V, Vitali F, Sciarrone MA, Bisogni G, Verdolotti T, Maceroni M, Minnella AM, Luigetti M (2023) Central nervous system involvement in two siblings affected by hereditary transthyretin amyloidosis 30 years after liver transplantation: a model for gene-silencing therapies. Neurol Res 45:773\u2013778","journal-title":"Neurol Res"},{"key":"13120_CR34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a0fe74","author":"K Hagiwara","year":"2009","unstructured":"Hagiwara K, Ochi H, Suzuki S, Shimizu Y, Tokuda T, Murai H, Shigeto H, Ohyagi Y, Iwata M, Iwaki T, Kira J (2009) Highly selective leptomeningeal amyloidosis with transthyretin variant Ala25Thr. Neurology. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a0fe74","journal-title":"Neurology"},{"key":"13120_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308107","author":"L Maia","year":"2015","unstructured":"Maia L, Magalh\u00e3es R, Freitas J, Taipa R, Pires M, Os\u00f3rio H, Dias D, Pessegueiro H, Correia M, Coelho T (2015) CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2014-308107","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13120_CR36","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/brain\/122.10.1951","volume":"122","author":"K-i Misu","year":"2024","unstructured":"Misu K-i, Hattori N, Nagamatsu M, Ikeda S-i, Ando Y, Nakazato M, Takei Y-i, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G (2024) Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan: clinicopathological and genetic features. Brain 122:1951\u20131962","journal-title":"Brain"},{"key":"13120_CR37","doi-asserted-by":"publisher","DOI":"10.1080\/13506120400000715","author":"T Oide","year":"2004","unstructured":"Oide T, Arima K, Yamazaki M, Hanyu N, Ikeda S (2004) Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family\u2013a follow-up autopsy report. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. https:\/\/doi.org\/10.1080\/13506120400000715","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"13120_CR38","doi-asserted-by":"publisher","DOI":"10.3129\/i09-023","author":"K Schweitzer","year":"2009","unstructured":"Schweitzer K, Ehmann D, Garcia R, Alport E (2009) Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His. Can J Ophthalmol J Can D\u2019ophtalmologie. https:\/\/doi.org\/10.3129\/i09-023","journal-title":"Can J Ophthalmol J Can D\u2019ophtalmologie"},{"key":"13120_CR39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003001","author":"Y Sekijima","year":"2016","unstructured":"Sekijima Y, Yazaki M, Oguchi K, Ezawa N, Yoshinaga T, Yamada M, Yahikozawa H, Watanabe M, Kametani F, Ikeda S (2016) Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000003001","journal-title":"Neurology"},{"key":"13120_CR40","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s12350-021-02890-6","volume":"29","author":"K Takahashi","year":"2022","unstructured":"Takahashi K, Sasaki D, Yamashita M, Sakaue T, Enomoto D, Morioka H, Uemura S, Okura T, Ikeda S, Kono T, Hiratsuka Y, Saijo A, Yamamura N, Kitazawa S, Yamashita T, Ueda M (2022) Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis. J Nucl Cardiol 29:3126\u20133136","journal-title":"J Nucl Cardiol"},{"key":"13120_CR41","doi-asserted-by":"publisher","first-page":"816636","DOI":"10.3389\/fneur.2022.816636","volume":"13","author":"EI Uneus","year":"2022","unstructured":"Uneus EI, Wilhelmsson C, B\u00e4ckstr\u00f6m D, Anan I, Wixner J, Pilebro B, Riklund K, \u00d6gren M, \u00d6green M, Axelsson J, Suhr OB, Sundstr\u00f6m T (2022) Cerebellar and cerebral amyloid visualized by [(18)F]flutemetamol PET in long-term hereditary V30M (p.V50M) transthyretin amyloidosis survivors. Front Neurol 13:816636","journal-title":"Front Neurol"},{"key":"13120_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/13506120600551814","volume":"13","author":"Y Shimizu","year":"2006","unstructured":"Shimizu Y, Takeuchi M, Matsumura M, Tokuda T, Iwata M (2006) A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis 13:37\u201341. https:\/\/doi.org\/10.1080\/13506120600551814","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"13120_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2019.1583179","author":"T Yamashita","year":"2019","unstructured":"Yamashita T, Ohnishi K, Ueda M, Masuda T, Inoue Y, Misumi Y, Ueda A, Obayashi K, Takeya M, Ando Y (2019) Transthyretin amyloid-related cerebral angiitis after liver transplantation. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. https:\/\/doi.org\/10.1080\/13506129.2019.1583179","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"4","key":"13120_CR44","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1212\/WNL.47.4.988","volume":"47","author":"M Herrick","year":"1996","unstructured":"Herrick M, DeBruyne K, Horoupian D, Skare J, Vanefsky M, Ong T (1996) Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurol 47(4):988\u2013992. https:\/\/doi.org\/10.1212\/WNL.47.4.988","journal-title":"Neurol"},{"key":"13120_CR45","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.5.1462","author":"C Klein","year":"1998","unstructured":"Klein C, Nakumura M, Jacobson D, Lacy M, Benson M, Petersen R (1998) Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy. Neurology. https:\/\/doi.org\/10.1212\/WNL.51.5.1462","journal-title":"Neurology"},{"key":"13120_CR46","doi-asserted-by":"publisher","unstructured":"Gillmore J, Booth D, Pepys M, Hawkins P (1999) Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man. Heart (British Cardiac Society) 82(3). https:\/\/doi.org\/10.1136\/hrt.82.3.e2","DOI":"10.1136\/hrt.82.3.e2"},{"issue":"4","key":"13120_CR47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/13506120400000749","volume":"11","author":"S Mitsuhashi","year":"2004","unstructured":"Mitsuhashi S, Yazaki M, Tokuda T, Yamamoto K, Ikeda S (2004) MRI analysis on a patient with the V30M mutation is characteristic of leptomeningeal amyloid. Amyloid 11(4):265\u2013267. https:\/\/doi.org\/10.1080\/13506120400000749","journal-title":"Amyloid"},{"issue":"8","key":"13120_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1468-1331.2005.01005.x","volume":"12","author":"HS Kim","year":"2005","unstructured":"Kim HS, Kim SM, Kang SW, Jung SC, Lee KS, Kim TS, Choi YC (2005) An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene. Eur J Neurol 12(8):657\u2013659. https:\/\/doi.org\/10.1111\/j.1468-1331.2005.01005.x","journal-title":"Eur J Neurol"},{"key":"13120_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-006-0709-5","author":"P De Carolis","year":"2006","unstructured":"De Carolis P, Galeotti M, Ficarra G, Masetti M, Grimaldi D, Cortelli P (2006) Fatal cerebral haemorrhage after liver transplantation in a patient with transthyretin variant (gly53glu) amyloidosis. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. https:\/\/doi.org\/10.1007\/s10072-006-0709-5","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"13120_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.07.007","author":"R Roe","year":"2007","unstructured":"Roe R, Fisher Y, Eagle R, Fine H, Cunningham E (2007) Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene. Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2007.07.007","journal-title":"Ophthalmology"},{"issue":"4","key":"13120_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/13506129.2012.724035","volume":"19","author":"J Levy","year":"2012","unstructured":"Levy J, Hawkins P, Rowczenio D, Godfrey T, Stawell R, Zamir E (2012) Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly. Amyloid 19(4):201\u2013203. https:\/\/doi.org\/10.3109\/13506129.2012.724035","journal-title":"Amyloid"},{"key":"13120_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7594-2","author":"P McColgan","year":"2015","unstructured":"McColgan P, Viegas S, Gandhi S, Bull K, Tudor R, Sheikh F, Pinney J, Fontana M, Rowczenio D, Gillmore J, Gilbertson J, Whelan C, Shah S, Jaunmuktane Z, Holton J, Schott J, Werring D, Hawkins P, Reilly M (2015) Oculoleptomeningeal amyloidosis associated with transthyretin Leu12Pro in an African patient. J Neurol. https:\/\/doi.org\/10.1007\/s00415-014-7594-2","journal-title":"J Neurol"},{"key":"13120_CR53","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13256-017-1407-z","volume":"11","author":"B Terrier","year":"2017","unstructured":"Terrier B, Colombat M, Beugnet C, Qu\u00e9ant A, London J, Daudin J, Le Jeunne C, Mouthon L, Monnet D, Cauquil C, Lacroix C, Adams D, Br\u00e9zin A, Valleix S (2017) Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report. J Med Case Rep 11:222. https:\/\/doi.org\/10.1186\/s13256-017-1407-z","journal-title":"J Med Case Rep"},{"key":"13120_CR54","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.wneu.2017.12.096","volume":"111","author":"FM Mathieu","year":"2018","unstructured":"Mathieu FM, ErinSoMunozMasonKongkham MJDGWP (2018) Oculoleptomeningeal amyloidosis secondary to the rare thransthyretin c.381T>G (p.Ile127Met) mutation. World Neurosurg 111:190\u2013193","journal-title":"World Neurosurg"},{"key":"13120_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.033","author":"F Salvi","year":"2018","unstructured":"Salvi F, Volpe R, Pastorelli F, Bianchi A, Vella A, Rapezzi C, Mascalchi M (2018) Failure of tafamidis to halt progression of Ala36Pro TTR oculomeningovascular amyloidosis. J Stroke Cerebrovasc Dis Off J Nat Stroke Assoc. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.04.033","journal-title":"J Stroke Cerebrovasc Dis Off J Nat Stroke Assoc"},{"key":"13120_CR56","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000001054","author":"L Cechin","year":"2021","unstructured":"Cechin L, Gasmelseed J, Bashford J, Rowczenio D, Reilly M, Gillmore J, Coutinho E (2021) Early-onset leptomeningeal manifestation of G47R hereditary transthyretin amyloidosis. Neurol Clin Pract. https:\/\/doi.org\/10.1212\/CPJ.0000000000001054","journal-title":"Neurol Clin Pract"},{"key":"13120_CR57","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0000000000000337","author":"Q Qin","year":"2021","unstructured":"Qin Q, Wei C, Piao Y, Lian F, Wu H, Zhou A, Wang F, Zuo X, Han Y, Lyu J, Guo D, Jia J (2021) Current review of leptomeningeal amyloidosis associated with transthyretin mutations. Neurologist. https:\/\/doi.org\/10.1097\/NRL.0000000000000337","journal-title":"Neurologist"},{"key":"13120_CR58","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.12809\/hkjr2217296","volume":"25","author":"BCK Chow","year":"2022","unstructured":"Chow BCK, Lo SSM, Lee JCY, Chiang JB, Chan HF, Ho CB, Szeto LT, Tang KW (2022) Familial amyloidotic polyneuropathy with leptomeningeal and cardiac involvement in a patient with Gly73Glu transthyretin gene mutation\u2014non-invasive diagnostic approach with multimodality imaging findings: a case report. Hong Kong J Radiol 25:E19\u2013E23","journal-title":"Hong Kong J Radiol"},{"key":"13120_CR59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/19418744221127849","volume":"13","author":"N Carberry","year":"2023","unstructured":"Carberry N, Yu S, Fayerman RN, Dugue R, Miller M, Tanji K, Goyal T, Canoll P, Brannagan TH (2023) Leptomeningeal disease secondary to Thr60Ala transthyretin amyloidosis: case report and review of the literature. Neurohospitalist 13:90\u201395","journal-title":"Neurohospitalist"},{"issue":"10","key":"13120_CR60","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/brain\/122.10.1951","volume":"122","author":"K Misu","year":"1999","unstructured":"Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G (1999) Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 122(10):1951\u20131962. https:\/\/doi.org\/10.1093\/brain\/122.10.1951","journal-title":"Clinicopathological and genetic features. Brain"},{"key":"13120_CR61","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.1.135","author":"E Ellie","year":"2001","unstructured":"Ellie E, Camou F, Vital A, Rummens C, Grateau G, Delpech M, Valleix S (2001) Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology. https:\/\/doi.org\/10.1212\/WNL.57.1.135","journal-title":"Neurology"},{"issue":"3","key":"13120_CR62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/01.TP.0000111516.60013.E6","volume":"77","author":"Y Ando","year":"2004","unstructured":"Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y (2004) A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplant 77(3):345\u2013349. https:\/\/doi.org\/10.1097\/01.TP.0000111516.60013.E6","journal-title":"Transplant"},{"issue":"8","key":"13120_CR63","first-page":"2043","volume":"26","author":"T Hirai","year":"2005","unstructured":"Hirai T, Ando Y, Yamura M, Kitajima M, Hayashida Y, Korogi Y, Yamashita T, Yamashita Y (2005) Transthyretin-related familial amyloid polyneuropathy: evaluation of CSF enhancement on serial T1-weighted and fluid-attenuated inversion recovery images following intravenous contrast administration. AJNR Am J Neuroradiol 26(8):2043\u20132048","journal-title":"AJNR Am J Neuroradiol"},{"key":"13120_CR64","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000178983.20975.af","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Yamashita T, Ueda M, Obayashi K, Sato T, Ikeda T, Washimi Y, Hirai T, Kuwahara Y, Yamamoto M, Uchino M, Ando Y (2005) Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000178983.20975.af","journal-title":"Neurology"},{"issue":"4","key":"13120_CR65","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/13506129.2018.1534731","volume":"25","author":"S Andreou","year":"2018","unstructured":"Andreou S, Panayiotou E, Michailidou K, Pirpa P, Hadjisavvas A, El Salloukh A, Barnes D, Antoniou A, Agathangelou P, Papastavrou K, Christodoulou K, Tanteles G, Kyriakides T (2018) Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset. Amyloid 25(4):220\u2013226. https:\/\/doi.org\/10.1080\/13506129.2018.1534731","journal-title":"Amyloid"},{"issue":"3","key":"13120_CR66","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00259-017-3814-1","volume":"45","author":"N Ezawa","year":"2018","unstructured":"Ezawa N, Katoh N, Oguchi K, Yoshinaga T, Yazaki M, Sekijima Y (2018) Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11 C-PiB PET imaging. Eur J Nucl Med Mol Imagin 45(3):452\u2013461. https:\/\/doi.org\/10.1007\/s00259-017-3814-1","journal-title":"Eur J Nucl Med Mol Imagin"},{"key":"13120_CR67","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.294550","author":"M Nagappa","year":"2020","unstructured":"Nagappa M, Sinha S, Mahadevan A, Bindu P, Krishnan K, Ray S, Debnath M, Bharath R, Rangan K, Jena S, Mathuranath P, Taly A (2020) Genetically established familial amyloidotic polyneuropathy from India: narrating the diagnostic \u201cOdyssey\u201d and a mini review. Neurol India. https:\/\/doi.org\/10.4103\/0028-3886.294550","journal-title":"Neurol India"},{"key":"13120_CR68","doi-asserted-by":"publisher","unstructured":"Carvalho V, Cunha C, Rocha R, Massano J, Correia F, Coelho P, Fran\u00e7a S, Cruz V, Cruto C (2021) Transthyretin amyloid-related transitory events (TARTEs): Descriptive analysis of clinical, imagiological, and neurophysiological features. J Neurol Sci 429. https:\/\/doi.org\/10.1016\/j.jns.2021.118068","DOI":"10.1016\/j.jns.2021.118068"},{"key":"13120_CR69","doi-asserted-by":"publisher","unstructured":"Banydeen R, Signate A, Tran TH, Monfort A, Neviere R, Inamo J (2022) Cerebral Ischemic Events: An Overlooked Complication of Transthyretin Cardiac Amyloidosis in Afro-Caribbean Patients. Front Neurol 13. https:\/\/doi.org\/10.3389\/fneur.2022.878292","DOI":"10.3389\/fneur.2022.878292"},{"key":"13120_CR70","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001975","author":"N Wange","year":"2018","unstructured":"Wange N, Anan I, Ericzon B, Pennlert J, Pilebro B, Suhr O, Wixner J (2018) Atrial fibrillation and central nervous complications in liver transplanted hereditary transthyretin amyloidosis patients. Transplantation. https:\/\/doi.org\/10.1097\/TP.0000000000001975","journal-title":"Transplantation"},{"key":"13120_CR71","doi-asserted-by":"publisher","DOI":"10.1097\/01.LAB.0000059937.11023.1F","author":"Y Sekijima","year":"2003","unstructured":"Sekijima Y, Hammarstr\u00f6m P, Matsumura M, Shimizu Y, Iwata M, Tokuda T, Ikeda S, Kelly J (2003) Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Investig J Tech Methods Pathol. https:\/\/doi.org\/10.1097\/01.LAB.0000059937.11023.1F","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"13120_CR72","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/13506129.2022.2128331","volume":"30","author":"Y Takahashi","year":"2023","unstructured":"Takahashi Y, Oguchi K, Mochizuki Y, Takasone K, Ezawa N, Matsushima A, Katoh N, Yazaki M, Sekijima Y (2023) Distribution and progression of cerebral amyloid angiopathy in early-onset V30M (p. V50M) hereditary ATTR amyloidosis. Amyloid 30:109\u2013118","journal-title":"Amyloid"},{"key":"13120_CR73","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1016\/S0021-9258(18)93118-2","volume":"244","author":"AGDS RazGoodman","year":"1969","unstructured":"RazGoodman AGDS (1969) The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. J Biol Chem 244:3230\u20133237","journal-title":"J Biol Chem"},{"key":"13120_CR74","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.neurobiolaging.2007.04.007","volume":"29","author":"JQ Brouillette","year":"2008","unstructured":"Brouillette JQ, R\u00e9mi. (2008) Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging 29:1721\u20131732","journal-title":"Neurobiol Aging"},{"key":"13120_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002899","author":"R Costa","year":"2008","unstructured":"Costa R, Ferreira-da-Silva F, Saraiva M, Cardoso I (2008) Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0002899","journal-title":"PLoS ONE"},{"key":"13120_CR76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s42466-021-00155-8","volume":"3","author":"MF Dohrn","year":"2021","unstructured":"Dohrn MF, Medina J, Olaciregui Dague KR, Hund E (2021) Are we creating a new phenotype? Physiological barriers and ethical considerations in the treatment of hereditary transthyretin-amyloidosis. Neurol Res Pract 3:57","journal-title":"Neurol Res Pract"},{"key":"13120_CR77","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00415-025-12950-3","volume":"272","author":"V Di Stefano","year":"2025","unstructured":"Di Stefano V, Guaraldi P, Romano A, Antonini G, Barilaro A, Briani C, Burattini M, Cani I, Carlini G, Ceccanti M, Cianci V, Cortelli P, Curr\u00f2 Dossi M, Di Lisi D, Di Muzio A, Falzone Y, Filosto M, Gasverde S, Gemelli C, Luigetti M (2025) Patisiran in ATTRv amyloidosis with polyneuropathy: \u201cPatisiranItaly\u201d multicenter observational study. J Neurol 272:209","journal-title":"J Neurol"},{"key":"13120_CR78","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/13506129.2018.1479249","volume":"25","author":"C Monteiro","year":"2018","unstructured":"Monteiro C, Martins da Silva A, Ferreira N, Mesgarzadeh J, Novais M, Coelho T, Kelly JW (2018) Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients. Amyloid 25:120\u2013128","journal-title":"Amyloid"},{"key":"13120_CR79","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00401-022-02501-9","volume":"145","author":"R Taipa","year":"2023","unstructured":"Taipa R, Sousa L, Pinto M, Reis I, Rodrigues A, Oliveira P, Melo-Pires M, Coelho T (2023) Neuropathology of central nervous system involvement in TTR amyloidosis. Acta Neuropathol 145:113\u2013126","journal-title":"Acta Neuropathol"},{"key":"13120_CR80","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07846-5","author":"I Senem","year":"2024","unstructured":"Senem I, Foss MP, Lavigne-Moreira C, dos Santos AC, de Fran\u00e7a Nunes RF, Fran\u00e7a J\u00fanior MC, Tomaselli PJ, Axelsson J, Wixner J, Marques W Jr (2024) Exploring cognitive functions and brain structure in hereditary transthyretin amyloidosis using brain MRI and neuropsychological assessment. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-024-07846-5","journal-title":"Neurol Sci"},{"key":"13120_CR81","volume-title":"Cognitive screening instruments","author":"AJ Mitchell","year":"2013","unstructured":"Mitchell AJ (2013) The mini-mental state examination (MMSE): an update on its diagnostic validity for cognitive disorders. In: Larner A (ed) Cognitive screening instruments. Springer, London"},{"key":"13120_CR82","doi-asserted-by":"publisher","DOI":"10.1080\/23279095.2016.1178645","author":"TR Kaemmerer","year":"2016","unstructured":"Kaemmerer TR, Patrick. (2016) Oral adaptation of the trail making test: a practical review. Appl Neuropsychol Adult. https:\/\/doi.org\/10.1080\/23279095.2016.1178645","journal-title":"Appl Neuropsychol Adult"},{"key":"13120_CR83","first-page":"499","volume":"15","author":"V Di Stefano","year":"2022","unstructured":"Di Stefano V, Fava A, Gentile L, Guaraldi P, Leonardi L, Poli L, Tagliapietra M, Vastola M, Fanara S, Ferrero B, Giorgi M, Perfetto F, Russo M, Russo D (2022) Italian real-life experience of patients with hereditary transthyretin amyloidosis treated with Patisiran. Pharmacogenomics Pers Med 15:499\u2013514","journal-title":"Pharmacogenomics Pers Med"},{"key":"13120_CR84","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1007\/s10072-024-07494-9","volume":"45","author":"L Gentile","year":"2024","unstructured":"Gentile L, Mazzeo A, Briani C, Casagrande S, De Luca M, Fabrizi GM, Gagliardi C, Gemelli C, Forcina F, Grandis M, Guglielmino V, Iabichella G, Leonardi L, Lozza A, Manganelli F, Mussinelli R, My F, Occhipinti G, Fenu S, Luigetti M (2024) Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy. Neurol Sci 45:4563\u20134571","journal-title":"Neurol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13120-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T13:25:17Z","timestamp":1749907517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13120-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["13120"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13120-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"419"}}